CA2086566A1 - Inhibitor for absorption of digested and decomposed products of food and drink - Google Patents

Inhibitor for absorption of digested and decomposed products of food and drink

Info

Publication number
CA2086566A1
CA2086566A1 CA002086566A CA2086566A CA2086566A1 CA 2086566 A1 CA2086566 A1 CA 2086566A1 CA 002086566 A CA002086566 A CA 002086566A CA 2086566 A CA2086566 A CA 2086566A CA 2086566 A1 CA2086566 A1 CA 2086566A1
Authority
CA
Canada
Prior art keywords
drink
food
digested
absorption
decomposed products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002086566A
Other languages
English (en)
French (fr)
Inventor
Shigeo Ochi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kibun Foods Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2086566A1 publication Critical patent/CA2086566A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Non-Alcoholic Beverages (AREA)
CA002086566A 1991-12-31 1992-12-31 Inhibitor for absorption of digested and decomposed products of food and drink Abandoned CA2086566A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3359568A JPH05186357A (ja) 1991-12-31 1991-12-31 飲食物消化分解産物吸収抑制手段
JP359568/1991 1991-12-31

Publications (1)

Publication Number Publication Date
CA2086566A1 true CA2086566A1 (en) 1993-07-01

Family

ID=18465171

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002086566A Abandoned CA2086566A1 (en) 1991-12-31 1992-12-31 Inhibitor for absorption of digested and decomposed products of food and drink

Country Status (7)

Country Link
JP (1) JPH05186357A (enrdf_load_stackoverflow)
AU (1) AU3045592A (enrdf_load_stackoverflow)
CA (1) CA2086566A1 (enrdf_load_stackoverflow)
CH (1) CH684740A5 (enrdf_load_stackoverflow)
DE (1) DE4244588A1 (enrdf_load_stackoverflow)
FR (1) FR2685611B1 (enrdf_load_stackoverflow)
GB (1) GB2262888B (enrdf_load_stackoverflow)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG26979A (en) 2000-12-21 2015-03-01 Astrazeneca Ab Chemical compounds
GB0121337D0 (en) 2001-09-04 2001-10-24 Astrazeneca Ab Chemical compounds
GB0121621D0 (en) 2001-09-07 2001-10-31 Astrazeneca Ab Chemical compounds
GB0121622D0 (en) 2001-09-07 2001-10-31 Astrazeneca Ab Chemical compounds
ATE349214T1 (de) 2001-09-08 2007-01-15 Astrazeneca Ab Benzothiazepin und benzothiadiazepin derivative mit hemmender wirkung auf den säuretransport in den gallengängen zur behandlung von hyperlipidaemia
GB0209467D0 (en) 2002-04-25 2002-06-05 Astrazeneca Ab Chemical compounds
GB0213669D0 (en) 2002-06-14 2002-07-24 Astrazeneca Ab Chemical compounds
GB0304194D0 (en) 2003-02-25 2003-03-26 Astrazeneca Ab Chemical compounds
GB0307918D0 (en) * 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
AU2008202120B2 (en) * 2003-04-05 2009-12-17 Albireo Ab Use of an IBAT inhibitor for the treatment of prophylaxis of constipation
US20130225511A1 (en) 2010-11-04 2013-08-29 Per-Göran Gillberg Ibat inhibitors for the treatment of liver diseases
JO3301B1 (ar) 2013-04-26 2018-09-16 Albireo Ab تعديلات بلورية على إيلوبيكسيبات
CN106659726A (zh) 2014-06-25 2017-05-10 Ea制药株式会社 固体制剂及其着色防止或着色减少方法
EP3012252A1 (en) 2014-10-24 2016-04-27 Ferring BV Crystal modifications of elobixibat
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
CA3071285A1 (en) 2017-08-09 2019-02-14 Albireo Ab Cholestyramine granules, oral cholestyramine formulations and use thereof
CN112449637B (zh) 2018-06-05 2024-03-19 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
KR102811961B1 (ko) 2018-06-20 2025-05-22 알비레오 에이비 오데빅시바트의 결정 변형물
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
KR20210126053A (ko) 2019-02-06 2021-10-19 알비레오 에이비 벤조티아디아제핀 화합물 및 담즙산 조절제로서의 그의 용도
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
EP4069361B1 (en) 2019-12-04 2024-01-03 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
CN114761079B (zh) 2019-12-04 2024-05-28 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
JP7665620B2 (ja) 2019-12-04 2025-04-21 アルビレオ・アクチボラグ ベンゾチアジアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
EP4069359B1 (en) 2019-12-04 2024-01-03 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
ES3002777T3 (en) 2020-08-03 2025-03-07 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
JP2023549226A (ja) 2020-11-12 2023-11-22 アルビレオ エービー 進行性家族性肝内胆汁うっ滞症（ｐｆｉｃ）を処置するためのオデビキシバット
WO2022117778A1 (en) 2020-12-04 2022-06-09 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
TW202313579A (zh) 2021-06-03 2023-04-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2221139B1 (enrdf_load_stackoverflow) * 1973-03-13 1978-03-24 Nippon Kayaku Kk
DE3307816A1 (de) * 1983-03-02 1984-09-06 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin-haltiges pharmazeutisches praeparat und seine herstellung
GB8419245D0 (en) * 1984-07-27 1984-08-30 Reckitt & Colmann Prod Ltd Medicinal compositions
JPS61172815A (ja) * 1985-01-28 1986-08-04 Toshiyuki Nakajima 潤滑剤
GB8817015D0 (en) * 1988-07-16 1988-08-17 Reckitt & Colmann Prod Ltd Method of treatment
GB8910076D0 (en) * 1989-05-03 1989-06-21 Thackray C F Ltd Sterilisable lubricant
JPH03120227A (ja) * 1989-10-02 1991-05-22 Shigeo Ochi 飲食物消化分解産物吸収抑制剤

Also Published As

Publication number Publication date
DE4244588A1 (enrdf_load_stackoverflow) 1993-07-15
JPH05186357A (ja) 1993-07-27
FR2685611B1 (fr) 1994-06-10
GB9227128D0 (en) 1993-02-24
CH684740A5 (de) 1994-12-15
FR2685611A1 (fr) 1993-07-02
GB2262888B (en) 1996-07-24
AU3045592A (en) 1993-07-08
GB2262888A (en) 1993-07-07

Similar Documents

Publication Publication Date Title
CA2086566A1 (en) Inhibitor for absorption of digested and decomposed products of food and drink
DE60002331T3 (de) Zusammensetzungen zur erschaffung und behaltung der energie und der mentalen wachsamheit
JP4095115B2 (ja) アロエベラ抽出物、アロエベラ抽出物の製造方法、高血糖改善剤
US20180104299A1 (en) Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a satiation agent for the treatment of obesity
DE69630694T2 (de) Neutralisierung von sauren nahrungs- und arzneimitteln
US20110177175A1 (en) Dietary fiber compositions
DE2621000A1 (de) Zusammensetzung zur verhinderung von ernaehrungsmaengeln
US10449165B2 (en) Foods, systems, methods, and kits for providing electrolyte replacement
DE60132851T2 (de) Arzneimittel zur Vorbeugung, Linderung oder Behandlung von Hypertonie
Kioukia-Fougia et al. Synthetic and Natural Nutritional Supplements: Health
US20040096527A1 (en) Compositions for lowering serum cholesterol level
JP2006028051A (ja) 起床時疲労感改善剤、起床時疲労感改善用組成物、及びこれらを含む起床時疲労感改善用飲食物
JPH10265397A (ja) 肥満予防剤
JP3634721B2 (ja) 高脂血症の予防又は治療剤
US4273794A (en) Composition containing honey
KR20190046108A (ko) 휴대용 다이어트 건강보조식품
JPH0919276A (ja) 健康美容飲料
KR100584153B1 (ko) 생약소재에 의한 변비 개선용 농축액 및 그 제조방법
US6599522B2 (en) Triglyceride reducing agent
Kukkupuni et al. Ayurvedic digestion recipes—Jal Jeera and Churan
JP2011241216A (ja) モズク由来のフコイダンを含む食品
Goldstein et al. Dietary Supplements: Fact Versus Fiction
KR20230101959A (ko) 기능성 식품 첨가물이 함유된 솜사탕 제조용 분말
JPH0558898A (ja) 高脂血症治療・予防剤
Editorial Submission From the Editors... Answering Consumer Questions on Nutrition

Legal Events

Date Code Title Description
FZDE Dead